A U.S. Registry of Eosinophilic Esophagitis Patients Treated With DUPIXENT® As Standard of Care

Status: Recruiting
Location: See all (45) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE symptoms * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How difficult it is to swallow * How EoE symptoms have changed throughout the study

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Healthy Volunteers: f
View:

• Initiating treatment with DUPIXENT® for EoE according to the USPI

• Able to understand and complete registry-related questionnaires (including adolescents)

Locations
United States
Arkansas
Arkansas Childrens Hospital
RECRUITING
Little Rock
Arizona
Phoenix Childrens Hospital
RECRUITING
Phoenix
Arizona Digestive Health/GI Alliance
RECRUITING
Sun City
California
Scripps Clinic
RECRUITING
La Jolla
University of Southern California Keck School of Medicine
RECRUITING
Los Angeles
Colorado
Childrens Hospital Colorado
RECRUITING
Aurora
University of Colorado Anschutz Medical Campus
RECRUITING
Aurora
Rocky Mountain Gastroenterology
RECRUITING
Littleton
Connecticut
UConn Health
RECRUITING
Farmington
Yale School of Medicine
RECRUITING
New Haven
Florida
Gastroenterology of Greater Orlando
RECRUITING
Orange City
Orlando Health
RECRUITING
Orlando
Georgia
Emory Healthcare, Emory Clinic
RECRUITING
Atlanta
GI Care for Kids LLC
RECRUITING
Atlanta
Illinois
Comprehensive Gastrointestinal Health, LLC
RECRUITING
Libertyville
NorthShore University Health System
RECRUITING
Skokie
Kansas
Kansas Gastroenterology LLC
RECRUITING
Wichita
Kentucky
Allergy & Asthma Specialists, P.S.C.
RECRUITING
Owensboro
Massachusetts
Boston Childrens Hospital
RECRUITING
Boston
Boston Specialists
RECRUITING
Boston
Minnesota
Mayo Clinic
RECRUITING
Rochester
Missouri
Kansas City VA Medical Center
RECRUITING
Kansas City
Washington University in Saint Louis
RECRUITING
St Louis
Mississippi
GI Associates and Endoscopy Center
RECRUITING
Flowood
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Duke University
RECRUITING
Durham
New Jersey
Allergy Partners of N.J., P.C.
RECRUITING
Ocean City
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Weil Cornell Medicine NYP
RECRUITING
New York
Gastroenterology Group of Rochester LLP
RECRUITING
Rochester
Ohio
Great Lakes Gastroenterology Research, LLC
RECRUITING
Mentor
Pennsylvania
Susquehanna Research Group
RECRUITING
Camp Hill
Childrens Hospital of Philadelphia
RECRUITING
Philadelphia
University of Pennsylvania
RECRUITING
Philadelphia
South Carolina
Medical University of South Carolina
RECRUITING
Charleston
Palmetto Gastroenterology Clinical Research
RECRUITING
Summerville
Texas
Brooke Army Medical Center
RECRUITING
Fort Sam Houston
Baylor College of Medicine
RECRUITING
Houston
GI Alliance
RECRUITING
Southlake
Utah
Tanner Clinic
RECRUITING
Layton
University of Utah
RECRUITING
Salt Lake City
Virginia
University of Virginia
RECRUITING
Charlottesville
Washington
Seattle Children's Home Health Company
RECRUITING
Seattle
Washington Gastroenterology, GIA
RECRUITING
Tacoma
Wisconsin
Medical College of Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Clinical Trials Administrator
clinicaltrials@regeneron.com
844-734-6643
Time Frame
Start Date: 2024-11-22
Estimated Completion Date: 2030-05-09
Participants
Target number of participants: 300
Treatments
EoE Patients treated with DUPIXENT®
Sponsors
Collaborators: Sanofi
Leads: Regeneron Pharmaceuticals

This content was sourced from clinicaltrials.gov